Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control.
Poveda E, Tabernilla A, Fitzgerald W, Salgado-Barreira Á, Grandal M, Pérez A, Mariño A, Álvarez H, Valcarce N, González-García J, Bernardino JI, Gutierrez F, Fujioka H, Crespo M, Ruiz-Mateos E, Margolis L, Lederman MM, Freeman ML. Poveda E, et al. J Infect Dis. 2022 Mar 15;225(6):1040-1049. doi: 10.1093/infdis/jiaa375. J Infect Dis. 2022. PMID: 32603406 Free PMC article.
Correlation between the main clinical, imaging, and arthroscopy findings in patients with temporomandibular disorders.
Fernández-Ferro M, Fernández-González V, Salgado-Barreira Á, Santos-Armentia E, Valdés-Sarmiento P, Fernández-García A, Gómez-Rey D, Fernández-Sanromán J. Fernández-Ferro M, et al. Int J Oral Maxillofac Surg. 2023 Feb;52(2):237-244. doi: 10.1016/j.ijom.2022.08.007. Epub 2022 Aug 17. Int J Oral Maxillofac Surg. 2023. PMID: 35985912
Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis.
Seijas-Amigo J, Cordero A, Olmo RF, Cortez Quiroga GA, Fácila L, Salgado-Barreira Á, Reyes-Santías F, Romero-Menor C, Murillo JR, Rodríguez-Mañero M, Bello Mora MC, Valle A, Sandin M, Pamias RF, Bañeras J, García PB, Lorenzo MC, Sánchez-Alvarez S, López-Rodríguez L, González-Juanatey JR. Seijas-Amigo J, et al. J Cardiovasc Pharmacol. 2023 Jan 1;81(1):70-75. doi: 10.1097/FJC.0000000000001365. J Cardiovasc Pharmacol. 2023. PMID: 36219195
Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phase.
Seijas-Amigo J, Salgado-Barreira Á, Castelo-Dominguez R, Pérez-Álvarez MT, Ponce-Piñón B, Fernández-Silva M, Rodríguez-Barreiro M, Pereira-Pía M, Iglesias-Moreno JM, Gago-García M, Montáns-García R, Fernandez-Perez A, FragaGayoso D, Fernandez-Montenegro M, Riveiro-Barciela B, Rilla-Villar N, Cordero A, RodríguezMañero M, González-Juanatey JR. Seijas-Amigo J, et al. Among authors: salgado barreira a. Prim Care Diabetes. 2023 Aug;17(4):366-372. doi: 10.1016/j.pcd.2023.05.004. Epub 2023 May 23. Prim Care Diabetes. 2023. PMID: 37230813 Free article.
Effect of dapagliflozin on COVID-19 infection and risk of hospitalization.
Salgado-Barreira A, Seijas-Amigo J, Rodriguez-Mañero M, Piñeiro-Lamas M, Eiras S, Cordero A, Gonzalez-Juanatey JR, Figueiras A. Salgado-Barreira A, et al. J Antimicrob Chemother. 2023 Sep 5;78(9):2335-2342. doi: 10.1093/jac/dkad241. J Antimicrob Chemother. 2023. PMID: 37549309 Free PMC article.
56 results